Tirzepatide – 20 mg
Tirzepatide – 20 mg Tirzepatide 20mg isn't a standard FDA-approved maintenance dose for Mounjaro (diabetes) or Zepbound (weight loss) in the U.S., which max out at 15mg weekly, but it might be a higher, compounded dose used for weight management or in other regions, representing significant weight loss (around 20-21%) in trials, administered weekly via injection to help with blood sugar/weight by mimicking gut hormones (GIP & GLP-1), but comes with common GI side effects like nausea.
Research Use Only Disclaimer
FOR RESEARCH USE ONLY This product is not intended for human or animal use.Not for medical, diagnostic, therapeutic, metabolic, endocrine, GLP-related, GIP-related, or consumption purposes.No dosage, administration, or biological outcome claims are made or implied.Use is restricted to qualified laboratory research environments only.
❓Frequently Asked Questions
Is tirzepatide approved for GLP, GIP, metabolic, or endocrine use?
No. This peptide is supplied strictly for laboratory research purposes.
Does this product include a Certificate of Analysis (COA)?
Yes. Every batch includes a third-party verified COA.
Why is tirzepatide supplied in a 20 mg research format?
Higher-mass quantities support extended analytical testing, repeat experimentation, and reference evaluation, not application or use.
Can this compound be used in humans or animals?
No. It is not approved for use in living systems.
How is this product classified?
It is classified solely as a research peptide, not a drug, supplement, or therapeutic agent.